Cargando…
Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy
Numerous cathepsin B inhibitors have been developed and are under investigation as potential cancer treatments. They have been evaluated for their ability to inhibit cathepsin B activity and reduce tumor growth. However, they have shown critical limitations, including low anticancer efficacy and hig...
Autores principales: | Park, So-Hyeon, Lee, Jun-Hyuck, Yang, Seong-Bin, Lee, Dong-Nyeong, Kang, Tae-Bong, Park, Jooho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141979/ https://www.ncbi.nlm.nih.gov/pubmed/37111617 http://dx.doi.org/10.3390/pharmaceutics15041131 |
Ejemplares similares
-
Peptide-Based Bioconjugates and Therapeutics for Targeted Anticancer Therapy
por: Yang, Seong-Bin, et al.
Publicado: (2022) -
Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules
por: Banik, Nipa, et al.
Publicado: (2021) -
Regulation of Caspase-8 Activity at the Crossroads of Pro-Inflammation and Anti-Inflammation
por: Han, Jun-Hyuk, et al.
Publicado: (2021) -
Nanomechanical In Situ Monitoring of Proteolysis of Peptide by Cathepsin B
por: Kwon, Taeyun, et al.
Publicado: (2009) -
Novel Activity of ODZ10117, a STAT3 Inhibitor, for Regulation of NLRP3 Inflammasome Activation
por: Kang, Ju-Hui, et al.
Publicado: (2023)